Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.4%

2 terminated out of 37 trials

Success Rate

92.9%

+6.4% vs benchmark

Late-Stage Pipeline

24%

9 trials in Phase 3/4

Results Transparency

15%

4 of 26 completed with results

Key Signals

4 with results93% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (9)
Early P 1 (1)
P 2 (3)
P 3 (1)
P 4 (8)

Trial Status

Completed26
Recruiting4
Unknown4
Terminated2
Not Yet Recruiting1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 26 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT07568509Early Phase 1Recruiting

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

NCT04897802Phase 4CompletedPrimary

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

NCT07143266RecruitingPrimary

Sleep Disorders in Hypothalamic and Pituitary Damage

NCT07015645Completed

Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas

NCT05990491Recruiting

Pituitary Function After Recovery From Septic Shock Among ICU Survivors

NCT06326853Not Yet Recruiting

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

NCT05319301Not ApplicableCompleted

Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)

NCT04902235Phase 4CompletedPrimary

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

NCT06014398Not ApplicableUnknownPrimary

Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours

NCT04121780Phase 2Recruiting

Growth Hormone Replacement Therapy for Retried Professional Football Players

NCT05206149Phase 4CompletedPrimary

Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes

NCT05188131Phase 4CompletedPrimary

Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium

NCT00507104Completed

Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH)

NCT00851942Phase 4Completed

Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test

NCT02782208Not ApplicableCompletedPrimary

Lipolytic Effects of GH in Hypopituitary Patients in Vivo

NCT00504218TerminatedPrimary

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

NCT03708523UnknownPrimary

Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy

NCT02360046Not ApplicableTerminatedPrimary

The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids in Patients With Corticotropic Hypopituitarism

NCT01007071Phase 3CompletedPrimary

Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency

NCT01209416Not ApplicableCompleted

The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin

Scroll to load more

Research Network

Activity Timeline